Scientists warn: Covid-19 vaccine can induce severe neurodegenerative disease in young population

Translated by: MOS Gospel Term – linli

On January 14th, Dr. Stephanie Seneff, a senior research scientist at MIT’s Computer Science and Artificial Intelligence Laboratory in Cambridge, Massachusetts, told Fox News that vaccinating young people against Covid-19 could lead to “an alarming increase in several major neurodegenerative diseases.” And it is “outrageous” to vaccinate the young because they have a “very low risk” of Covid-19 death.

Dr. Stephanie Seneff, a senior research scientist at MIT worries surprising increased prevalence of neurodegenerative disease among younger populations in the coming years.

“When you look at the potential harm of these vaccines, it doesn’t make any sense,” Dr. Seneff said, “Repeated boosters will be very disruptive in the long run.”

Dr. Seneff told Laura Ingraham in Fox News that she performed “a lot of research” to map out the mechanism of potential Covid-19 vaccine-induced neurodegenerative disease in later life. 

“It’s very disturbing,” she said. Her research discovered that both mRNA vaccines and DNA-vectored vaccines might be avenues for disabling disease at some point in the future. Through the prion-like effects of the spike protein, we may see a surprising increased prevalence of the neurodegenerative disease among younger populations in the coming years, including Parkinson’s disease, chronic kidney disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease.

“Unfortunately, we don’t know whether vaccines contribute to this increased risk because there is often a long time lag between vaccination events and disease diagnosis.”

“It’s convenient for vaccine makers, who can make huge profits from our misfortune — both from the sale of the vaccine itself and the treatment of all these debilitating diseases. Huge medical bills.”

Proofread/Edited/Posted by: Wenfei


Disclaimer: This article only represents the author’s view. Gnews is not responsible for any legal risks.

Inline Feedbacks
View all comments